Cited by 1,163Lipoproteins and Cardiovascular HealthCholesterol and Lipid MetabolismParaoxonase enzyme and polymorphisms

The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.

A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarction.

Open access

Stampfer, Meir J., Sacks, Frank M., Salvini, Simonetta, Willett, Walter C., Hennekens, Charles H.·1991·New England Journal of Medicine

DOI 10.1056/nejm199108083250601

Open this paper in CoChat — free account Open PDF

Abstract

BACKGROUND: The independent contributions of subfractions of high-density lipoprotein (HDL) cholesterol (HDL2 and HDL3) and apolipoproteins in predicting the risk of myocardial infarction are unclear. Prospective data are sparse, but HDL2 is widely believed to be a more important predictor than HDL3. METHODS: Blood samples were collected at base line from 14,916 men (ages, 40 to 84 years) who were participants in the Physicians' Health Study. After five years of follow-up, plasma samples from 246 men with new myocardial infarction (case subjects) were analyzed together with specimens from 246 men matched to them for age and smoking status who had not had a myocardial infarction. RESULTS: The levels of total cholesterol and apolipoprotein B-100 were significantly associated with an increased risk of myocardial infarction (data on levels of low-density lipoprotein cholesterol were unavailable). Both HDL cholesterol and HDL2 levels were associated with a substantially decreased risk of myocardial infarction, but the HDL3 level was the strongest predictor; the relative risk was 0.3 (95 percent confidence interval, 0.2 to 0.6) for those in the fifth of the group with the highest HDL3 levels, as compared with the fifth with the lowest levels. The benefit of a higher HDL cholesterol level was most pronounced among those with lower total cholesterol levels. Levels of apolipoprotein A-I and apolipoprotein A-II were also associated with decreased risk. However, the levels of HDL subfractions and apolipoproteins did not add significantly to the value of a multivariate model that included the ratio of total to HDL cholesterol in predicting myocardial infarction, whereas that ratio remained a significant independent predictor of risk. After adjustment for other risk factors, a change of one unit in the ratio of total to HDL cholesterol was associated with a 53 percent change in risk (95 percent confidence interval, 26 percent to 85 percent). CONCLUSIONS: This study underscores the importance of HDL cholesterol in predicting the risk of myocardial infarction and demonstrates protective effects of both the HDL3 and HDL2 subfractions of HDL cholesterol. We found little or no predictive value for the levels of apolipoproteins A-I, A-II, and B or HDL subfractions after conventional risk factors and the ratio of total to HDL cholesterol were considered.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1056/nejm199108083250601

Cites

56 of 56 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

From the New York Times Magazine
Minsky, & Hyman, P. (1979) · Cited by 6,899
High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies.
Gordon, D. J., Probstfield, J. L., Garrison, R. J., Neaton, J. D., Castelli, W. P., Knoke, J. D., Jacobs, D. R., Bangdiwala, S., & Tyroler, H. A. (1989) · Circulation · doi:10.1161/01.cir.79.1.8 · Cited by 3,162
Incidence of Coronary Heart Disease and Lipoprotein Cholesterol Levels
Castelli, W. P. (1986) · JAMA · doi:10.1001/jama.256.20.2835 · Cited by 2,512
Final Report on the Aspirin Component of the Ongoing Physicians' Health Study
Steering Committee of the Physicians' Health Study Research Group (1989) · New England Journal of Medicine · doi:10.1056/nejm198907203210301 · Cited by 2,267
THE TROMSØHEART-STUDY
Miller, N. E., Thelle, D. S., Førde, O. H., & Mjøs, O. D. (1977) · The Lancet · doi:10.1016/s0140-6736(77)92274-7 · Cited by 1,206
Separation and quantitation of subclasses of human plasma high density lipoproteins by a simple precipitation procedure
Gidez, L. I., Miller, G. J., Burstein, M., Slagle, S., & Eder, H. (1982) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)38059-7 · Cited by 757
Ischemic Heart Disease, Atherosclerosis, and Longevity
Gofman, J. W., Young, W., & Tandy, R. K. (1966) · Circulation · doi:10.1161/01.cir.34.4.679 · Cited by 587
Apolipoprotein A-I as a Marker of Angiographically Assessed Coronary-Artery Disease
Maciejko, J. J., Holmes, D. R., Kottke, B. A., Zinsmeister, A. R., Dinh, D. M., & Mao, S. J. T. (1983) · New England Journal of Medicine · doi:10.1056/nejm198308183090701 · Cited by 537
Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. The Expert Panel
Goodman, D. S., Hulley, S. B., Clark, L. T., Davis, C. E., Fuster, V., LaRosa, J. C., Oberman, A., Schaefer, E. J., Steinberg, D., Brown, W. V., et al. (1988) · Archives of Internal Medicine · doi:10.1001/archinte.148.1.36 · Cited by 529
ARE APOLIPOPROTEINS BETTER DISCRIMINATORS THAN LIPIDS FOR ATHEROSCLEROSIS?
Avogaro, P., Bon, G. B., Avogaro, P., Cazzolato, G., & Quinci, G. B. (1979) · The Lancet · doi:10.1016/s0140-6736(79)91375-8 · Cited by 523

Show all 56 references

Research works printed but not linked: 10

Enger, 1979, Artery, 5, 170
Bennett, 1988, New York Times Magazine, 55
Jones PH, Gotto AM Jr. Assessment of lipid abnormalities. In: Hurst JW, Schlant RC, Rachley CE, Sonnenblick EH, Wenger NK, eds. The heart: arteries and veins. 7th ed. New York: McGraw-Hill, 1990:378–84.
10.1001/archinte.150.8.1645 · DOI
Musliner, 1988, Clin Chem, 34, B78
Hennekens, 1987, Circulation, 76, IV-501
Kempen, 1987, J Lab Clin Med, 109, 19
Avogaro P, Cazzolato G, Bittolo Bon G, Rorai E, Pontoglio E. Lipoprotein derangements in human atherosclerosis. In: Noseda G, Fragiacomo C, Fumagalli R, Paoletti R, eds. Lipoproteins and coronary atherosclerosis. Amsterdam: Elsevier, 1982:123–42.
Kladetzky, 1980, Artery, 7, 191
Desager JP, Rousseau M, Riesen WF, Harvengt C. Limitations of the predictive value for coronary vascular disease of plasma lipids and apoproteins AI, AII, B levels as measured before coronarography in 317 patients. In: de Gennes JL, Polonovski J, Paoletti R, eds. Latent dyslipoproteinemias and atherosclerosis. New York: Raven Press, 1984:165–74.

Sorted by citations

Items 901–999 of 999

Het faillissement van de verzadigd vethypothese van cardiovasculaire ziektes
Muskiet, F. A. J., Muskiet, M. H. A., & Kuipers, R. S. (2012) · Pure Amsterdam UMC · Cited by 4
Serum Lipid Levels and M/L55 Allele Distribution of HDL Paraoxonase Gene in Saami and Finnish Men
Malin, R., Lehtinen, S., Luoma, P. V., Näyhä, S., Hassi, J., Koivula, T. A., & Lehtimäki, T. J. (2001) · International Journal of Circumpolar Health · doi:10.1080/22423982.2001.12112993 · Cited by 4
BMP1 5′UTR + 104 T/C gene variation: can be a predictive marker for serum HDL and apoprotein A1 levels in male patients with coronary heart disease
Akadam-Teker, B., Özkara, G., Gömleksiz, Ö. K., Buğra, Z., Teker, E., Öztürk, O., & Yılmaz, H. (2018) · Molecular Biology Reports · doi:10.1007/s11033-018-4283-8 · Cited by 4
High-Density Lipoprotein Cholesterol
Toth, P. P., & Gotto, A. M. (2006) · Fundamental and clinical cardiology · doi:10.3109/9781420019667.008 · Cited by 5
Periodic health examination, 1993 update: 2. Lowering the blood total cholesterol level to prevent coronary heart disease. Canadian Task Force on the Periodic Health Examination.
(1993) · Europe PMC (PubMed Central) · Cited by 4
Are apolipoproteins A and B better than lipoproteins for assessing risk of obstructive coronary heart disease?
Manfrói, W. C., Zago, A. J., Campos, M., Alves, A., Brisolara, M. L., de Souza, J., Candiago, R. H., Kirschnick, L., Ribeiro, L. W., Ordovás, K., et al. (1999) · Arquivos Brasileiros de Cardiologia · doi:10.1590/s0066-782x1999000600001 · Cited by 4
Lipoprotein Subfraction Analysis Using Nuclear Magnetic Resonance Spectroscopy
Cromwell, W. C., Bays, H. E., & Toth, P. P. (2007) · doi:10.1002/9780470691984.ch19 · Cited by 4
Is there anything to add to our lipid risk factors for coronary heart disease?
Sacks, F. M. (1995) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)80774-7 · Cited by 4
Self-citation
New developments in the prevention of atherosclerosis in patients with low high-density lipoprotein cholesterol
Brousseau, M. E., & Schaefer, E. J. (2001) · Current Atherosclerosis Reports · doi:10.1007/s11883-001-0074-z · Cited by 4
CGP 43371 paradoxically inhibits development of rabbit atherosclerotic lesions while inducing extra-arterial foam cell formation
Feldman, D. L., Sawyer, W. K., Jeune, M. R., Mogelesky, T. C., LINDEN‐REED, J. V., & PRESCOTT, M. F. (2001) · Atherosclerosis · doi:10.1016/s0021-9150(00)00492-5 · Cited by 4
Lipoproteins and apolipoproteins in the young and familial risk of coronary atherosclerosis
Uiterwaal, C. S. P. M., Witteman, J. C. M., van Stiphout, W. A. H. J., Krauss, X. H., de Bruijn, A. M., Albert Hofman, D., & Grobbee, D. E. (1996) · Atherosclerosis · doi:10.1016/0021-9150(95)05758-7 · Cited by 4
Spinal cord injury and physical activity, wheelchair performance in rehabilitation and sports
Dallmeijer, A. J. (1998) · University of Groningen research database (University of Groningen / Centre for Information Technology) · Cited by 4
Cardiovascular Disease
Scbulte, P. A., Rothman, N., & Austin, M. A. (1993) · Elsevier eBooks · doi:10.1016/b978-0-08-092566-0.50017-3 · Cited by 4
[HDL cholesterol in children. Its influence on the diagnosis of hypercholesterolemia].
Bayle, M. S., & Ruiz, M. L. F. (1997) · PubMed · Cited by 4
Association of Serum Triglyceride-to-High-density Lipoprotein Cholesterol Ratio with Insulin Resistance and Non-alcoholic Fatty Liver Disease in Children and Adolescents
Üstyol, A., Kökali, F., Duru, N. S., & Elevli, M. (2018) · Medical Bulletin of Haseki · doi:10.4274/haseki.30074 · Cited by 3
Comparaison de la biotolérance de l’huile extraite de l’arille de Blighia sapida (K. Koenig), des huiles de palme et d’olive chez le rat
OUATTARA, H. D., Amonkan, A. K., Meïté, A., & Coulibaly, S. K. (2014) · Afrique Science Revue Internationale des Sciences et Technologie · doi:10.4314/afsci.v10i1.226 · Cited by 3
Effect of Dietary Fatty Acid Intake on Cardiovascular Disease
Joris, P. J., & Mensink, R. P. (2015) · Elsevier eBooks · doi:10.1016/b978-1-78242-247-1.00007-7 · Cited by 3
The prognostic impact of HDL-C level in patients presenting with ST-elevation myocardial infarction
Amrawy, A. M. E., Almaghraby, A. M., & Abdelnabi, M. H. (2023) · British Journal of Cardiology · doi:10.5837/bjc.2023.005 · Cited by 3
Dyslipidemia in stroke
Cynthia, A., Yogeesha, K. S., & Arunachalam, R. (2014) · IOSR Journal of Dental and Medical Sciences · doi:10.9790/0853-13464549 · Cited by 3
Application of Gas Chromatography – Flame Ionization Detection to Study Cellular Incorporation of Dietary Trans Fatty Acids of Medical Importance
Somogyi, A., Mátyási, J., Gór‐Nagy, Z., Sarnyai, F., Csala, M., & Tóth, B. (2021) · Periodica Polytechnica Chemical Engineering · doi:10.3311/ppch.16646 · Cited by 3
Lipoprotein Subclasses and Cardiovascular Disease Risk in Insulin-Resistant Diabetes
Cobble, M. E., Mize, P. D., & Brinton, E. A. (2013) · Contemporary diabetes · doi:10.1007/978-1-4614-7554-5_2 · Cited by 3
Sensory comparison of doughnuts fried in trans fat‐free oil to those fried in oil containing trans fats
Bordi, P. L., Hack, D. M., Rager, M. D., & Hessert, S. W. (2007) · Journal of Foodservice · doi:10.1111/j.1745-4506.2007.00069.x · Cited by 2
Effects of hydrochlorothiazide and captopril on lipoprotein lipid composition in patients with essential hypertension
Jd, B., Buchanan, W., Pollare, T., & Lithell, H. (1996) · European Journal of Clinical Pharmacology · doi:10.1007/bf00203777 · Cited by 3
Apolipoproteins and lipoprotein particles in moroccan patients with previous myocardial infarction
Adlouni, A., Messal, M. E., Ghalim, N., & Saı̈le, R. (1997) · International Journal of Clinical & Laboratory Research · doi:10.1007/bf02912466 · Cited by 3
Provision of laboratory services for lipid analysis in the United Kingdom
Hutchesson, A. C. J., O’Kane, M., Neely, R. D. G., & Oleesky, D. A. (2007) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1258/000456307780480891 · Cited by 3
High density lipoprotein can modulate the inhibitory effect of oxLDL on prostacyclin generation by rat aorta in vitro
Mahfouz, M. M., & Kummerow, F. A. (2003) · Prostaglandins & Other Lipid Mediators · doi:10.1016/s1098-8823(03)00054-6 · Cited by 3
Alcohol: ¿tónico o tóxico cardiovascular?
Estruch, R., & Sacanella, E. (2005) · Clínica e Investigación en Arteriosclerosis · doi:10.1016/s0214-9168(05)73339-8 · Cited by 3
Effects of Fats and Oils on Rheological, Fatty Acid Profile and Quality Characteristics of South Indian Parotta
Kumar, H. C. T., Jeyarani, T., Milind, & Indrani, D. (2013) · Journal of the American Oil Chemists Society · doi:10.1007/s11746-013-2301-5 · Cited by 3
Do favourable effects of increasing unsaturated fat intake on cardiovascular disease risk outweigh the potential adverse effect on body weight?
Zock, P. L. (2006) · International Journal of Obesity · doi:10.1038/sj.ijo.0803486 · Cited by 3
Extracorporeal Treatment of Familial Hypercholesterolemia With Monoclonal Antibodies to Low-Density Lipoprotein
Wingard, R. L., Lee, W. O., & Hakim, R. M. (1991) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(12)80650-0 · Cited by 3
Lifestyle Change and High‐Density Lipoprotein Change: The US Department of Veterans Affairs Normative Aging Study
Rahilly‐Tierney, C. R., Vokonas, P., Gaziano, J. M., & Spiro, A. (2012) · Clinical Cardiology · doi:10.1002/clc.21978 · Cited by 3
When and how to measure lipids and their role in CHD risk prediction
Richmond, W. (2003) · The British Journal of Diabetes · doi:10.1177/14746514030030030601 · Cited by 3
Predictor of cardiovascular disease with respect to BMI, WHR and lipid profile in females of three population groups
Bishnoi, D., Kaur, T., & Badaruddoza, B. (2010) · Biology and medicine · Cited by 3
Evaluation of Iyengariastellata for its hypolipidemic and hepatoprotective activity.
Riaz, B., Najam, R., Anser, H., & Ali, M. S. (2014) · PubMed · Cited by 3
Seguimiento de 5 años del perfil lipídico en los niños. Estudio Rivas-Vaciamadrid
Sánchez-Bayle, M., Bernardo, A. S., Antón, J. A., Quemada, C. R.-J., Baeza, J., & José, M. S. (2005) · Anales de Pediatría · doi:10.1157/13076765 · Cited by 3
Perfil lipídico en niños de Rivas-Vaciamadrid. Seguimiento de 2 años
de Salazar, M. J. P. G., Bayle, M. S., Gonzalez‐Requejo, A., Quemada, C. R.-J., Antón, J. A., & de Becerra, J. O. (2000) · Anales de Pediatría · doi:10.1016/s1695-4033(00)77377-2 · Cited by 3
Increased serum triglyceride clearance and elevated high-density lipoprotein 2 and 3 cholesterol during treatment of primary hypertriglyceridemia with bezafibrate
SAKUMA, N., Ikeuchi, R., Hibino, T., Yoshida, T., Mukai, S., Akita, S., Yajima, K., Miyabe, H., Goto, T., Takada, N., et al. (2003) · Current Therapeutic Research · doi:10.1016/j.curtheres.2003.10.002 · Cited by 3
Trans fats – should we be worried?
Aisbitt, B., & Buttriss, J. (2006) · Nutrition Bulletin · doi:10.1111/j.1467-3010.2006.00589.x · Cited by 3
The effect of medroxyprogesterone acetate and clomiphene citrate on platelet function in menopausal women
Tepper, R., Bar, J., Goldberger, S. B., Fuchs, J., Beyth, Y., & Ovadia, J. (1996) · Maturitas · doi:10.1016/0378-5122(95)01001-7 · Cited by 3
Apolipoprotein A-I of Hyperlipidemia Atherosclerosis Prone (LAP) Quail: cDNA Sequence and Tissue Expression
Iwasaki, H., Oku, H., Toda, T., Nasu, T., Koji, O. D. A., Miyagi, T., & Chinen, I. (1999) · Bioscience Biotechnology and Biochemistry · doi:10.1271/bbb.63.29 · Cited by 3
Both HDL3 and HDL2 Exert a Powerful Anti-Oxidative and Protective Effect against Acceleration of Oxidative Modification of LDL by Ascorbic Acid
SAKUMA, N., Saeki, T., Yajima, K., Hibino, T., Yoshida, T., MIZUNO, H., Mukai, S., SAKATA, S., KUNIMATSU, M., & Kimura, G. (2005) · Journal of Nutritional Science and Vitaminology · doi:10.3177/jnsv.51.75 · Cited by 3
Risk factor surveillance for coronary heart disease in Sofia, Bulgaria
Georgieva, L. (1999) · Open Research Online - ORO (The Open University) · doi:10.21954/ou.ro.0000fd32 · Cited by 3
Relationships between serum levels of autoantibodies against oxidized low density lipoproteins, lipid-soluble antioxidants and apolipoprotein B in patients with coronary heart disease.
Bakalova, R., Hadzhimitova, V., & Ribarov, S. R. (2000) · PubMed · Cited by 3
Prevention of cardiovascular disease
Barbir, M., Lazem, F., & Ilsley, C. D. J. (1996) · Developments in cardiovascular medicine · doi:10.1007/978-94-011-5406-2_35 · Cited by 3
The Reversibility of Obesity, Diabetes, Hyperlipidemia, and Coronary Heart Disease
Anderson, J. W., & Akanji, A. O. (1994) · Humana Press eBooks · doi:10.1007/978-1-4684-8136-5_10 · Cited by 3
Valores del perfil lipídico y de los índices CT/C-HDL, C-LDL/C-HDL, Apo B/A e índice aterogénico, en niños de 6 años de Rivas-Vaciamadrid
Jose, M., de Salazar, M. J. P. G., Bayle, M. S., Barral, M., Quemada, C. R.-J., & Antón, J. A. (1998) · Anales de Pediatría · Cited by 3
Comparative Effectiveness of Lipid-Lowering Therapies in Increasing High-Density Lipoprotein Cholesterol Levels in Patients with Chronic Kidney Disease
Naim, M. A. A. Z., Thomas, F., Streja, E., Davis, R. L., Kalantar‐Zadeh, K., Sumida, K., & Kovesdy, C. P. (2026) · The Nephron journals/Nephron journals · doi:10.1159/000551276 · Cited by 2
A study of clinical profile and risk factors in Ischemic stroke with special reference to serum homocysteine and lipid profile: a cross sectional observation study
Mishra, T., Ishwar, A., Pandey, P., Singh, A., Chandrakar, M., & Pharmani, S. (2016) · International Journal of Advances in Medicine · doi:10.18203/2349-3933.ijam20162868 · Cited by 2
Association between atherogenic index of plasma and left ventricular hypertrophy in patients with chronic heart failure with mid-range ejection fraction
NIKOLOV, A. G., Blazheva, S. O., Kostadinovska, A., Kostov, K., & Tzekova, M. (2022) · Medicina Fluminensis · doi:10.21860/medflum2022_271160 · Cited by 2
Dynamics of HDL-Cholesterol Following a Post-Myocardial Infarction Cardiac Rehabilitation Program
Bertolín‐Boronat, C., Merenciano-Gonzalez, H., Marcos‐Garcés, V., Mas, M. L. M., Alberola, J. I. C., Pérez-Solé, N., López, L., Argente, M. C. E., Reig, M. V., Benito, A. A., et al. (2025) · Reviews in Cardiovascular Medicine · doi:10.31083/rcm25399 · Cited by 2
Development and sensory evaluation of a trans fat‐free sugar cookie
Bordi, P. L., Rager, M. D., Hack, D. M., & Hessert, S. W. (2007) · Journal of Foodservice · doi:10.1111/j.1745-4506.2007.00063.x · Cited by 2
HDL, apo B/apo A1 ratio, Diabetes Mellitus and Cardiovascular Disease
Sultan, D., Sachu, P., & Elshaari, F. A. (2013) · InTech eBooks · doi:10.5772/56476 · Cited by 2
Evaluación de la heterogeneidad y función de HDL por el laboratorio
Movva, R., & Rader, D. J. (2009) · Redalyc (Universidad Autónoma del Estado de México) · Cited by 2
[High and low density lipoprotein abnormalities in coronary patients with LDL-C at target and uncontrolled HDL-C and triglycerides].
Posadas‐Romero, C., Posadas‐Sánchez, R., Juárez-Rojas, J. G., Medina-Urrutia, A. X., Galarza, E. J., Cardoso-Saldaña, G. C., Caracas-Portilla, N., & Mendoza-Peŕez, E. (2008) · PubMed · Cited by 2
Efeito do basquetebol em cadeira de rodas no colesterol-HDL de paraplégicos
Rodrigues, F. B. (2013) · ConScientiae Saúde · doi:10.5585/conssaude.v12n1.3790 · Cited by 2
HDL-cholestérol et risque cardiovasculaire : au-delà du LDL !
Bruckert, É., Farnier, M., & Ferrières, J. (2010) · Médecine des Maladies Métaboliques · doi:10.1016/s1957-2557(10)70081-x · Cited by 2
Can Conventional Risk Factors Explain Excess Coronary Artery Disease Risk in South Asians: Dyslipidemias and Dysfunctional High Density Lipoprotein (HDL)
Dodani, S. (2009) · The Open Epidemiology Journal · doi:10.2174/1874297100902010055 · Cited by 2
Association of apoprotein A-1 genetic variants with development of atherosclerosis in the population of St. Petersburg
Мирошникова, В. В., Rodygina, T. I., Demina, E. P., Kurianov, P., Urazgildeevа, S. A., Gurevich, V. S., & Schwarzman, A. L. (2011) · Russian Journal of Genetics Applied Research · doi:10.1134/s207905971105011x · Cited by 2
Simultaneous Screening for Three Correlated Lipids in the VA HDL Intervention Trial
Iwane, M. K., Wittes, J. T., Collins, D. E., & Bloomfield, H. E. (1999) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(99)00031-1 · Cited by 2
The Associations between Alcohol Intake and HDL Cholesterol Subclasses in Korean Population
Lim, J. E., Kim, J. I., Lee, S. J., Sull, J. W., Lee, M., & Jee, S. H. (2012) · Journal of Lipid and Atherosclerosis · doi:10.12997/jla.2012.1.2.61 · Cited by 2
Angiographic appearance of “tumour blush” produced by a large right atrial myxoma
Kumar, S., Kaul, S., Saha, P. K., & Miller, M. J. (2006) · Heart · doi:10.1136/hrt.2005.073684 · Cited by 2
The value of apoA-I in predicting heart disease and myocardial infarction
Schmidt, C. B., Bergström, G. M. L., & Sniderman, A. D. (2015) · Clinical Lipidology · doi:10.2217/clp.15.36 · Cited by 2
More on SI Units
Rubenstein, J. J., Gotto, A. M., & Grundy, S. M. (1992) · New England Journal of Medicine · doi:10.1056/nejm199207023270112 · Cited by 2
Lipoproteins and Apoproteins
Citkowitz, E., & Herbert, P. N. (1999) · Developments in cardiovascular medicine · doi:10.1007/978-1-4615-5007-5_3 · Cited by 2
Role of nutrigenomics in obesity, hypertension, and cardiovascular diseases
Lao-Polestico, R. R., Lim, M. V. B., Roy, M., Sankaralingam, P., Mariadoss, C. A., Sivaraj, A., & Mahankali, M. K. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-824412-8.00013-8 · Cited by 2
High-Density Lipoprotein Cholesterol and Triglycerides in Coronary Heart Disease Risk Assessment
Miller, M. J. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-28786-9.00009-8 · Cited by 2
Sucralfate on Serum Lipids and Lipoproteins in Normal Volunteers
Schwenk, M. H., Berk, S. I., Morgan, D. V., Maesaka, J. K., & Lehrer, M. (1994) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1994.tb02041.x · Cited by 2
Bridging the gap: Promoting physical activity among individuals with spinal cord injury within the context of the theory of planned behaviour
Latimer‐Cheung, A. E. (2005) · PsycEXTRA Dataset · doi:10.1037/e538502009-008 · Cited by 2
Efectos del alcohol sobre las lipoproteínas
Nasiff-Hadad, A., Gira, P., & Bruckert, E. (1997) · DOAJ (DOAJ: Directory of Open Access Journals) · Cited by 2
Formación médica continuada sobre el uso de hipolipemiantes en ancianos de 65-75 años
García, A. R., Villares, J. E., Tabernero, B. H., Hernán, J. C. H., Sosa, G. D. P., & López, F. J. G. (2001) · Atención Primaria · doi:10.1016/s0212-6567(01)78804-x · Cited by 2
Cardiovascular Risk Assessment in Elderly Individuals
Fleury, J., & Keller, C. (2000) · Journal of Gerontological Nursing · doi:10.3928/0098-9134-20000501-10 · Cited by 2
Effects of gemfibrozil on plasma lipoproteins, plasma activities of hepatic enzymes, and hemostatic variables in hypertriglyceridemic patients
Heller, F., Parfonry, A., Descamps, O. S., Desager, J., & Harvengt, C. (1995) · Current Therapeutic Research · doi:10.1016/0011-393x(95)85052-x · Cited by 2
Oxidative Stress and Risk of Cardiovascular Disease Associated with Low- and High-Monounsaturated Fat Portfolio Diets
Chiavaroli, L. (2010) · TSpace (University of Toronto) · Cited by 2
Arginine and Old MACE
Levin, R. I. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.03.011 · Cited by 2
Studies on the severity and extent of coronary atherosclerosis utilizing computer-assisted quantification of coronary angiograms : With special reference to diabetes mellitus
Pajunen, P. (2002) · Työväentutkimus Vuosikirja · Cited by 2
Nutritional and Health Aspects of Olive Oil and Diseases
Lenart, E., Kiritsakis, A., & Willett, W. (2017) · doi:10.1002/9781119135340.ch26 · Cited by 2
Self-citation
HDL and cardiovascular risk
Romero-Jiménez, M. J. (2024) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2024.119050 · Cited by 3
Quantum Dots and Doped Nanocrystals: Synthesis, Optical Properties, and Bio-applications
Zhao, Y. (2013) · Utrecht University Repository (Utrecht University) · doi:10.13140/rg.2.2.32338.15047 · Cited by 2
DEFINING THE AFRICAN GREEN MONKEY (CHLOROCEBUS AETHIOPS): EXPRESSION BEHAVIOUR OF SELECTED LIPID METABOLISM GENES IN RESPONSE TO NIACIN
Chauke, C. G. (2012) · UWC Research Repository (University of the Western Cape) · Cited by 2
Potential effect of insulin resistance and cardiovascular risk factors on metabolic syndrome in subjects with normal fasting plasma glucose levels
Jeong, D. W., Lee, J. G., Lee, S. Y., Kim, Y. J., Bae, J. H., Kim, D., Yi, Y. H., Cho, Y. H., & Chae, U. (2012) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-012-0069-z · Cited by 1
Association Between HDL2-C and HDL3-C with Cardiovascular Disease: A Nested Case-Control Study in an Iranian Population
Chary, A., Tohidi, M., Hasheminia, M., Golmohammadi, M., Hajihosseini, R., Hedayati, M., Azizi, F., & Hadaegh, F. (2023) · Intern J Endocrinol Metab · doi:10.5812/ijem-141550 · Cited by 1
Elevated triglyceride–glucose index increases risk in patients with retinal vein occlusion
Lv, B., Xia, K., Yang, Y., Song, Z., Xing, Y., Yang, A., & Ji, K. (2026) · Frontiers in Medicine · doi:10.3389/fmed.2025.1702069 · Cited by 1
Residual Risk Reduction Initiative: výzva ke snížení reziduálního vaskulárního rizika u pacientů s dyslipidemií
Fruchart, J., Sacks, F. M., Hermans, M. P., Assmann, G., Brown, W. V., Češka, R., Chapman, M. J., Dodson, P. M., Fioretto, P., Ginsberg, H. N., et al. (2010) · Cor et Vasa · doi:10.33678/cor.2010.056 · Cited by 1
Self-citation
Enfermedad del hígado graso no alcohólico y riesgo cardiovascular
Hernando, Á. B., & Puzo, J. (2010) · Clínica e Investigación en Arteriosclerosis · doi:10.1016/j.arteri.2010.10.004 · Cited by 1
Significance of Determining Levels of Apolipoproteins A-I and B in the Diagnostics and Assessment of Lipid-Related Atherogenic Risk in Hyperalpha-Lipoproteinemia, Hypocholesterolemia and Hypo-Hdl-Cholesterolemia
Kojić-Damjanov, S., Đerić, M., Čabarkapa, V., & Vučurević-Ristić, L. (2007) · Journal of Medical Biochemistry · doi:10.2478/v10011-007-0024-6 · Cited by 1
Natural micronutrients as controlling factors in Western diseases — A lesson in nature-programming
VILLIERS, L. S. D. (1994) · Medical Hypotheses · doi:10.1016/0306-9877(94)90092-2 · Cited by 1
SEQUENCE VARIATION IN THE APOA2 GENE AND ITS RELATIONSHIP WITH PLASMA HDL-CHOLESTEROL LEVELS
Hollister, S. M. (2008) · D-Scholarship@Pitt (University of Pittsburgh) · Cited by 1
Effecten van vetzuren in de voeding op de totaal-, LDL- en HDL-cholesterol- concentraties
Mensink, R. P. (2005) · Cited by 1
Trans fatty acids and cardiometabolic syndrome.
Juturu, V. (2009) · Cited by 1
Pattern of Abnormal Serum Lipids and Lipoprotein Ratios in Nigerian Hypertensive Patients Seen in Clinical Practice
Ajayi, E. A., Ajayi, A. O., & Adeyeye, V. O. (2015) · Journal of Advances in Medicine and Medical Research · doi:10.9734/bjmmr/2015/15021 · Cited by 1
Efficacy and Rapid Response of Tocilizumab in Rheumatoid Arthritis Patients not Responder to Previous Biologic Therapy
Parisi, S. (2017) · MOJ Orthopedics & Rheumatology · doi:10.15406/mojor.2017.08.00317 · Cited by 1
Evaluation of atherogenic lipoprotein-cholesterol to HDL cholesterol ratio as a prognostic test for ST-segment elevation myocardial infarction
Li, J., Xu, W., Zhou, Z. G., Zhang, R.-L., Sun, T., Xu, H., & Wu, J. (2021) · International Journal of Medical Sciences · doi:10.7150/ijms.44801 · Cited by 1
Association of High-Density Lipoprotein Cholesterol Subfractions with Insulin Resistance in Nigerians with Type 2 Diabetes Mellitus
Onwukwe, C. H., Chikezie, N. I., Okorie, K., Nwani, P. O., & Ohwovoriole, A. E. (2021) · Journal of Diabetology · doi:10.4103/jod.jod_18_21 · Cited by 1
Medical Management of Glaucoma
Cantor, L. B., WuDunn, D., Gerber, S. L., Catoira-Boyle, Y. P., & Allen, R. C. (2008) · Elsevier eBooks · doi:10.1016/b978-1-4160-0016-7.50220-4 · Cited by 1
Novel Lipid Indices as a Better Marker of Cardiovascular Disease Risk in Postmenopausal Women
Sirigere, M., & Meera, S. (2017) · Indian Journal of Medical Biochemistry · doi:10.5005/jp-journals-10054-0017 · Cited by 1
Influence of Impaired Masticatory Function on the Nutrition of Completely Edentulous Patients
Deogade, S. C., Naitam, D., Patil, S., & Surgeon, D. (2015) · Cited by 1
Comparison of direct and precipitation methods for the estimation of major serum lipoproteins
Mulinge, J. M., Waithaka, S., & Kaggia, S. N. N. (2017) · East African Medical Journal · Cited by 1
Assessment of Lipid Profile and Atherogenic Indexes of Hepatitis B Virus Carriers amongst Volunteer Blood Donors in Nigeria
Odiabara, K. K., Nwachuku, E. O., Boisa, N., & Bartimaeus, E.-A. S. (2020) · Journal of Biosciences and Medicines · doi:10.4236/jbm.2020.84007 · Cited by 1
Prevalence of atherogenic dyslipidemia in young asymptomatic medical professionals of a Tertiary Care Hospital in South India: A cross-sectional study
Rani, R. A. J., K, D. P., & Shanthi, R. (2020) · International Journal of Clinical Biochemistry and Research · doi:10.18231/j.ijcbr.2020.086 · Cited by 1

Authors: Stampfer, M. J., Sacks, F. M., Salvini, S., Willett, W. C., & Hennekens, C. H.
Affiliations: Brigham and Women's Hospital (US)
ORCID: Stampfer, Meir J.
Sacks, Frank M.
Willett, Walter C.
Hennekens, Charles H.
Venue: New England Journal of Medicine
Publisher: Massachusetts Medical Society
Published: 1991-08-08
Volume: 325
Issue: 6
Pages: 373-381
ISSN: 0028-4793 (ISSN-L)
1533-4406
DOI: 10.1056/nejm199108083250601
OpenAlex: W2337032743
Cited by: 1,163
References: 56
Citations by year: 2026: 6 · 2025: 5 · 2024: 10 · 2023: 10 · 2022: 7 · 2021: 12 · 2020: 14 · 2019: 12 · 2018: 18 · 2017: 17 · 2016: 24 · 2015: 31 · 2014: 34 · 2013: 33 · 2012: 31
FWCI: 80.75
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: New England Journal of Medicine (publishedVersion)
PubMed (publishedVersion)
Funders: National Heart, Lung, and Blood Institute (HL-34595, HL 26490, R01HL034595)
National Cancer Institute (R01CA042182, CA 42182)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Paraoxonase enzyme and polymorphisms
Keywords: myocardial infarction, HDL cholesterol, HDL2, HDL3, apolipoprotein B-100, apolipoprotein A-I, apolipoprotein A-II, TC/HDL-C ratio, cardiovascular risk prediction, total cholesterol, men, Physicians' Health Study, lipoprotein subfractions, risk factors, coronary heart disease prevention, statin therapy
MeSH terms: Adult, Aged, Aged, 80 and over, Apolipoproteins, Apolipoproteins A, Apolipoproteins B, Cholesterol, Humans, Cholesterol, HDL, Male, Middle Aged, Myocardial Infarction, Prospective Studies, Risk Factors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarction.

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks